IMCC IM Cannabis Corp. stock chart & analysis
Conviction 40Scan · Tue, Nov 10, 2026IM Cannabis Corp. (IMCC) closed at $0.5941 (-5.17%) on Nov 10, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 28, RS Rating 1, -99.2% from its 52-week high, -98.8% year to date.
Why IMCC moved
From the StockSetups movers recaps that covered IMCC, newest first. A recap states what was known that day.
- Premarket+54.4%
There are no headlines or SEC filings of note for IMCC this morning — the most recent filings are routine 6-K foreign-event disclosures from late August and early September. The catalyst is unclear. With short interest of only 12,539 shares and 0.1 days to cover, a short squeeze is not the driver.
Premarket Movers Sept 22, 2026: LHSW, DCOY, TOPS → - Close+140.8%
No researched catalyst, confirmed headline, or earnings release is on file for today. The most recent SEC filings are neutral 6-Ks from late August and early September reporting routine foreign events.
Top Stock Movers Sept 18, 2026: IMCC, REFR, GIPR → - Premarket+69.3%
IM Cannabis Corp. is up +69.3% to $2.98 premarket on 22.0 million shares — a jaw-dropping 31.6× its 20-day average volume of just 698,261 shares. That relative-volume explosion in a cannabis company with a $2.1M market cap is the first thing that stands out.
Premarket Movers Sept 18, 2026: GIPR, TNMG, IMCC → - Close+3,400.9%
A press release on PR Newswire dated August 27 confirmed that IMCC shares commenced trading on a 30:1 consolidated basis — meaning every 30 old shares were converted into 1 new share.
Top Stock Movers Today — August 27, 2026: Why IMCC, WHLR, CELU, PPCB & LGPS Surged →
IMCC technical analysis
Trend
IMCC is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 65.8% below the 50-day ($1.74) and 94.7% below the 200-day ($11.31). ADX(14) at 14 points to a weak trend — more range than direction. It meets 0 of 8 trend-template criteria.
Momentum
RSI(14) is 28, in oversold territory. MACD crossed above its signal line 7 sessions ago. A bullish MACD divergence is in place. Its RS Rating of 1 puts its weighted 12-month performance ahead of about 1% of the US market.
Volume and volatility
Volume on the latest session ran 0.0× its 20-day average. It trades about $61,030 a day on average. ATR(14) is $0.1979, 33.3% of price — its typical daily range. On-balance volume is trending down. Chaikin Money Flow (-0.07) shows distribution.
Key levels
The chart pattern's support is $0.6866 and its resistance $5.11. The 52-week range is $0.5805 to $72.80; price is 99.2% below the high and 2.3% above the low. The VWAP anchored at the 52-week high is $4.83, above price.
Performance
IMCC returned -18.0% (1 week), -59.3% (1 month), -86.9% (3 months), -93.3% (6 months), -98.7% (1 year), -98.8% (year to date).
About IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
Listed 1997 · 44 employees
SEC filings
EDGAR filings in IMCC · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.